Epidermal growth factor inhibits amiloride-sensitive sodium absorption in renal collecting duct cells

Am J Physiol Renal Physiol. 2003 Jan;284(1):F57-64. doi: 10.1152/ajprenal.00028.2002. Epub 2002 Aug 27.

Abstract

The effects of the ERK pathway on electrogenic transepithelial Na(+) absorption by renal collecting duct cells were determined. Approximately 90% of the unstimulated short-circuit current (15 +/- 1 microA/cm(2), n = 10) across conditionally immortalized murine collecting duct epithelial cells (mCT1) is amiloride sensitive and is likely mediated by apical epithelial Na(+) channels. Chronic exposure (24 h) of the epithelial monolayers to either EGF (50 ng/ml) or transforming growth factor-alpha (TGF-alpha; 20 ng/ml) reduced amiloride-sensitive short-circuit current by >60%. The inhibitory effect of EGF on Na(+) absorption was not due to inhibition of basolateral Na(+)-K(+)-ATPase, because the pump current elicited by permeabilization of apical membrane with nystatin was not reduced by EGF. Chronic exposure of the mCT1 cells to EGF (20 ng/ml, 24 h) elicited a 70-85% decrease in epithelial Na(+) channel subunit mRNA levels. Exposure of mCT1 cells to either EGF (20 ng/ml) or PMA (150 nM) induced rapid phosphorylation of p42/p44 (ERK1/2) and pretreatment of the monolayers with PD-98059 (an ERK kinase inhibitor; 30 microM) prevented phosphorylation of p42/p44. Similarly, pretreatment of mCT1 monolayers with PD-98059 prevented the EGF- and PMA-induced inhibition of amiloride-sensitive Na(+) absorption. The results of these studies demonstrate that amiloride-sensitive Na(+) absorption by renal collecting duct cells is regulated by the ERK pathway. This pathway may play a role in alterations in ion transport that occur in polycystic kidney disease.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Amiloride / pharmacology*
  • Animals
  • Antineoplastic Agents / pharmacology
  • Carcinogens / pharmacology
  • Cell Line, Transformed
  • Cell Membrane / metabolism
  • Diuretics / pharmacology*
  • Dose-Response Relationship, Drug
  • Epidermal Growth Factor / pharmacology*
  • Epithelial Sodium Channels
  • Gene Expression / drug effects
  • Gene Expression / physiology
  • Kidney Tubules, Collecting / cytology
  • Kidney Tubules, Collecting / drug effects
  • Kidney Tubules, Collecting / metabolism*
  • MAP Kinase Signaling System / drug effects
  • MAP Kinase Signaling System / physiology
  • Mice
  • Mitogen-Activated Protein Kinase 1 / metabolism
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinases / metabolism
  • Phosphorylation
  • Polycystic Kidney Diseases / metabolism
  • RNA, Messenger / analysis
  • Sodium / metabolism*
  • Sodium Channels / genetics
  • Sodium-Potassium-Exchanging ATPase / metabolism
  • Tetradecanoylphorbol Acetate / pharmacology
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • Antineoplastic Agents
  • Carcinogens
  • Diuretics
  • Epithelial Sodium Channels
  • RNA, Messenger
  • Sodium Channels
  • Tumor Necrosis Factor-alpha
  • Epidermal Growth Factor
  • Amiloride
  • Sodium
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • Mitogen-Activated Protein Kinases
  • Sodium-Potassium-Exchanging ATPase
  • Tetradecanoylphorbol Acetate